199 results on '"Corey, Kathleen"'
Search Results
2. Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD
3. CT Texture Analysis in Nonalcoholic Fatty Liver Disease (NAFLD)
4. Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine
5. Growth Hormone Administration Improves Nonalcoholic Fatty Liver Disease in Overweight/Obesity: A Randomized Trial
6. Genetic risk factors for NAFLD and clinically significant fibrosis in persons living with HIV
7. Liver fibrosis is associated with cardiovascular disease burden amongst patients with non-alcoholic steatohepatitis: the unCoVer-NASH longitudinal cohort study
8. Transgender Women with HIV Demonstrate Unique Non-Alcoholic Fatty Liver Disease Profiles
9. American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease
10. Serum Fibroblast Growth Factor-21 Discriminates Between Decompensated Alcohol-Associated Cirrhosis and Severe Alcohol-Associated Hepatitis
11. Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study
12. Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus
13. Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies
14. Proteomic Analysis of Hepatic Fibrosis in Human Immunodeficiency Virus–Associated Nonalcoholic Fatty Liver Disease Demonstrates Up-regulation of Immune Response and Tissue Repair Pathways
15. OR27-2 Growth Hormone Reduces Hepatic Steatosis, Inflammation and Fibrosis in Adults with Overweight/Obesity and Nonalcoholic Fatty Liver Disease
16. Risk factors for cardiovascular disease among individuals with hepatic steatosis
17. NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity?
18. Visualizing biomarkers and their association with clinical outcomes: A machine learning approach
19. Analysis of a Simulation Model to Estimate Long-term Outcomes in Patients with Nonalcoholic Fatty Liver Disease
20. Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
21. The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/Obesity
22. Reliability of histologic disease activity measures in non-alcoholic fatty liver disease (NAFLD) and development of an expanded NAFLD activity score
23. Results of the Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) study 1.1 on the reproducibility and repeatability of shear-wave and transient elastography in non-alcoholic fatty liver disease
24. Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature
25. Liver Stiffness by Transient Elastography Correlates With Degree of Portal Hypertension in Common Variable Immunodeficiency Patients With Nodular Regenerative Hyperplasia
26. Su1402: MENOPAUSAL STATUS IS INDEPENDENTLY ASSOCIATED WITH HEPATIC FIBROSIS RISK IN INDIVIDUALS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
27. Tu1319: EFFECT OF COMBINED TOBACCO USE AND DIABETES DIAGNOSIS ON PREVALENT FIBROSIS AMONG NAFLD PATIENTS
28. Su1403: ROLE OF METFORMIN IN REDUCING HEPATIC FIBROSIS AMONG NONDIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
29. Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score
30. TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis
31. Intermittent Fasting as a Treatment for Nonalcoholic Fatty Liver Disease: What Is the Evidence?
32. Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: Evidence from mediation analysis
33. Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus
34. ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD
35. Machine learning enables new insights into genetic contributions to liver fat accumulation
36. Bariatric Surgery as a Strategy for Improving Outcomes in Nonalcoholic Steatohepatitis
37. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
38. Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors
39. Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD
40. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease
41. Distinct Hepatic Gene‐Expression Patterns of NAFLD in Patients With Obesity
42. Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease
43. Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis
44. Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach
45. The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments
46. Growth Hormone Releasing Hormone Reduces Plasma Markers of Immune Activation and Hepatic Immune Pathways in Nonalcoholic Fatty Liver Disease
47. 656 SEDENTARY LIFESTYLE AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK SCORE PREDICT INCIDENT MAJOR ADVERSE CARDIOVASCULAR EVENTS IN SUBJECTS WITH HEPATIC STEATOSIS
48. Expression of IGF-1, IGF-1 Receptor and Growth Hormone Receptor in Hepatic Tissue in Adults Across the Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
49. Pro-Inflammatory Interleukin-18 is Associated with Hepatic Steatosis and Elevated Liver Enzymes in People with HIV Monoinfection
50. Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.